bezafibrate has been researched along with Encephalomyopathies, Mitochondrial in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, K; Lyu, J; Xin, W; Xu, X; Yan, C; Yu, W; Zhang, N; Zhao, Y; Zheng, R | 1 |
| Diaz, F; Dillon, L; Hida, A; Lellek, V; Moraes, CT; Noe, N; Wenz, T | 1 |
2 other study(ies) available for bezafibrate and Encephalomyopathies, Mitochondrial
| Article | Year |
|---|---|
Bezafibrate Rescues Mitochondrial Encephalopathy in Mice via Induction of Daily Torpor and Hypometabolic State.
Topics: Animals; Bezafibrate; Disease Models, Animal; Electron Transport Complex I; Hypoglycemic Agents; Mice; Mice, Knockout; Mitochondrial Encephalomyopathies; Peroxisome Proliferator-Activated Receptors; Torpor | 2022 |
RETRACTED: Bezafibrate improves mitochondrial function in the CNS of a mouse model of mitochondrial encephalopathy.
Topics: Adenosine Triphosphate; Alkyl and Aryl Transferases; Animals; Astrocytes; Bezafibrate; Cell Proliferation; Disease Models, Animal; Hypolipidemic Agents; Membrane Proteins; Mice; Mitochondria; Mitochondrial Encephalomyopathies; Mitochondrial Proteins; Neuroprotective Agents; Treatment Outcome | 2013 |